Postoperative Pain
Conditions
Keywords
Compound lidocaine, Esketamine, Quadratus lumborum block, opioid consumption
Brief summary
Purpose: To explore effects of ultrasound-guided quadratus lumborum block with compound lidocaine and esketamine on postoperative pain after colorectal surgery.
Detailed description
Poor post-surgical pain control is a leading factor that hinders the physicalrehabilitation, and causes acute cognitive impairment and chronic painsyndrome. Recently, the multimodal analgesia strategies to minimise opioidrelated side effects are highly desirable in open surgical procedures. Quadratus lumborum block is a novel technique. Although ropivacaine is most commonly used forthis technique, the analgesic duration remains not dissatisfied. Compared with ropivacaine, compound lidocaine injection has a better and longer analgesic activity since it contains menthol and ethanol with appropriate concentrations. However, whether compound lidocaine injection is efficiency in the quadratus lumborum block for abdominal surgery lacks investigations. Herein, we will evaluate the efficacy of ultrasound-guided quadratus lumborum block (USG-QLB) with compound lidocaine injection and esketamine for postoperative analgesia in patients undergoing colorectal surgery.
Interventions
DRUGNormal saline
After the induction of anesthesia, normal saline is used for bilateral quadratus lumborum block in a volume of 20 mL of each side
DRUGRopivacaine
After the induction of anesthesia, 0.375% ropivacaine is used for bilateral quadratus lumborum block in a volume of 20 mL of each side
After the induction of anesthesia, 0.6% compound lidocaine is used for bilateral quadratus lumborum block in a volume of 20 mL of each side
DRUGEsketamine
After the induction of anesthesia, 0.4mg/kg esketamine is used for bilateral quadratus lumborum block
Sponsors
Tianjin Medical University General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Subject is scheduled to undergo colorectal cancer surgery under general anesthesia 2. Subject's American Society of Anesthesiologists physical status is I-III. 3. The subject's parent/legally authorized guardian has given written informed consent to participate
Exclusion criteria
1. Subject has a diagnosis of bronchial asthma, coronary heart disease, severe hypertension, renal failure or liver failure. 2. Subject has a diagnosis of Insulin dependent diabetes. 3. Subject is allergy and contraindication to local anesthetics or any components of local anesthetics. 4. Subject has a history of chronic pain, a history of alcohol or opioid abuse, pre- existing therapy with opioids, intake of any analgesic drug within 48 hours before surgery. 5. Subject has any contraindication for the use of patient-controlled analgesia (PCA). 6. Subject is pregnant or breast-feeding. 7. Subject is obese (body mass index \>30kg/m\^2). 8. Subject is incapacity to comprehend pain assessment and cognitive assessment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative opioid consumption | 72 hours after surgery | Each patient was administered analgesics using a PCA (Patient-controlled analgesia) pump containing opioid in normal saline after leaving PACU (Postanesthesia care unit). Opioid cumulative consumption is recorded for 72 hours postoperatively. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time of First Postoperative Analgesic Requirement | 1 hour after surgery | First postoperative pain (NRS≥5) is initially controlled by titration of opioid. |
| Total Dose of First Postoperative Analgesic Requirement | 1 hour after surgery | First postoperative pain (NRS≥5) is initially controlled by titration of opioid. |
| The incidence of Side Effects | 72 hours after surgery | The number of patients with side effects including nausea, vomiting, dizziness, headache, shivering, and pruritus is recorded for 72 hours postoperatively. |
| Apfel score | The 1 day before the surgery | The Apfel score was recorded for evaluating risk for developing postoperative nausea and vomiting (PONV). |
| Pain Score (NRS) | 72 hours after surgery | The pain score at rest or after movement was evaluated by pain 11-point numerical rating scale (NRS): 0 = no pain, 10= greatest imaginable pain. |
| Diffusion area of local anesthetics after quadratus lumborum block | 30 minutes after quadratus lumborum block | Diffusion area of local anesthetics after quadratus lumborum block was calculated under ultrasound assistance. |
| Normalized Area of Hyperalgesia Around the Incision | 72 hours after surgery | The skin around the incision is stimulated in steps of 5 mm at intervals of 1 s starting outside of the hyperalgesic area in the direction of the incision. The distance from the incision to the first point where a 'painful', 'sore' or 'sharper' feeling occurred is measured and noted. This measurement is repeated at predefined radial lines around the incision. To eliminate the variable length of incision, this length is subtracted from the longer diameter leaving four radial distances from the end and from the middle of the incision. The normalized area of hyperalgesia is calculated by summing up the areas of the remaining four triangles measured by and Von Frey filament. |
| The level of cytokines in blood By ELISA kits | 72 hours after surgery | Blood is collected to measure the level of cytokines (such as IL-18, IL-17, IL-23 ) using ELISA kits. |
| The level of chemokines in blood By ELISA kits | 72 hours after surgery | Blood is collected to measure the level of chemokines (such as CXCL1, CCL7, CCL2) using ELISA kits. |
| Mean time until passage of flatus | 96 hours after surgery | Gastrointestinal motility was evaluated by recording mean time until passage of flatus |
Contacts
Primary ContactGuolin Wang, MD
Outcome results
None listed